Navigation Links
Seroquel Sustained Release Schizophrenia Data Presented at ECP,Congress in Madrid

perienced a significantly reduced risk of relapse (risk reduction of 87 percent, p<0.0001), and a significantly longer time to relapse, compared with those on placebo. Differences in relapse rate between active treatment and placebo were large enough to require the study to be stopped early, in accordance with the study protocol. In the SEROQUEL® sustained release group, the estimated risk of relapse after six months was 14.3 percent versus 68.2 percent in the placebo group (p<0.0001). Hospitalisation due to worsening of schizophrenia was required by 8.3 percent of patients on placebo, but was not needed for any patients taking SEROQUEL® sustained release formulation.

Professor Rene Kahn, Professor and Chair of the Department of Psychiatry and Head of the Division of Neuroscience at the University Medical Center, Utrecht, said: “In these studies SEROQUEL® sustained release formulation showed its potential as a once-daily treatment for both acute and clinically stable schizophrenia. Statistical significance on the primary endpoint was seen at doses between 400 and 800 mg/day and patients achieved that range within two days of starting treatment – that is an advantage over original formulation quetiapine, where the initial dose escalation is not so simple. In mental healthcare, striving for treatment that is simpler and more practical is an important objective for patients and doctors.”

In both studies, somnolence and dizziness were the most common adverse events with SEROQUEL® sustained release formulation and these were generally mild or moderate, transient, and did not lead to withdrawal from the trials. The incidence of extrapyramidal adverse events was similar to placebo (EPS-related adverse events were seen in 5.1 percent of patients taking placebo versus 2.7 percent [400mg], 8.0 percent [600mg] and 4.1 percent [800mg] of patients taking SEROQUEL® sustained release formulation in the acute study).

Other
'"/>




Page: 1 2 3 4

Related medicine technology :

1. New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release Tablets as Effective Treatment for Schizophrenia
2. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
3. OREXIGEN Therapeutics Announces Sustained-Release Formulation of Zonisamide Shows Improved Tolerability When Compared to Immediate Release Formulation
4. Cervarix, the GSK Cervical Cancer Candidate Vaccine, Provides Sustained Immune Response in 100 Percent of Women up to 55 Years of Age
5. Long-Term Pegylated Interferon Alfa-2b Therapy in Stage III Melanoma Demonstrated Significant and Sustained Impact on Relapse-Free Survival
6. Medtronic Updates Long-Term ENDEAVOR I-II Clinical Data Showing Sustained Safety and Significant Reductions in Repeat Procedures
7. Copaxone Treatment over Two Years after Short Term Induction with Mitoxantrone Provided Sustained Benefits to Active Relapsing-Remitting Multiple Sclerosis Patients
8. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
9. Mayo Clinic News Release: Mayo Clinic-led Study Improves Breast Cancer Risk Prediction in Women with Atypia
10. Lupus Foundation of America Statement on Results for Clinical Study of CellCept Released by Aspreva Pharmaceutical Company
11. An Investigational Study Released at ADA Showed that Initial Combination Therapy with Januvia (sitagliptin) and Metformin Led to Improvement in Markers of Beta Cell Function in Patients with Type 2 Diabetes
Post Your Comments:
(Date:3/6/2015)... CHESTNUT RIDGE, N.Y. , March 6, 2015 ... it will host a conference call on Friday, ... review its results of operations for the fourth ... Par is privately held and currently makes certain ... filings with the Securities and Exchange Commission and ...
(Date:3/6/2015)... Research and Markets ( http://www.researchandmarkets.com/research/rvhg65/european_patient ) ... Handling Equipment Market by Product, by Type of Care, ... report to their offering. The ... at a double-digit CAGR of 11.4% to reach $5,150.2 ... rising geriatric population, increasing incidences of lifestyle diseases, and ...
(Date:3/6/2015)... March 6, 2015 ... de patients pouvant bénéficier de l,innovation thérapeutique.   ... d,enrichissement sémantique de contenu pour l,Entreprise, annonce que ... Groupe des Centres de lutte contre le cancer ... son projet ConSoRe (Continuum Soin-Recherche) conduit par la ...
Breaking Medicine Technology:European Patient Handling Equipment (Wheelchair, Scooters, Bathroom Safety Supply, Mechanical, Ambulatory) Market 2015-2019 2European Patient Handling Equipment (Wheelchair, Scooters, Bathroom Safety Supply, Mechanical, Ambulatory) Market 2015-2019 3TEMIS et SWORD accompagnent UNICANCER pour accélérer la recherche par l'analyse sémantique des dossiers patients 2TEMIS et SWORD accompagnent UNICANCER pour accélérer la recherche par l'analyse sémantique des dossiers patients 3TEMIS et SWORD accompagnent UNICANCER pour accélérer la recherche par l'analyse sémantique des dossiers patients 4
(Date:3/6/2015)... March 06, 2015 Further solidifying their ... Medical Doctor Associates announced today that the company has ... winning the Best of Staffing Talent Award five years ... Best of Staffing Talent Diamond winners are proven industry ... to them by the individuals they have helped find ...
(Date:3/6/2015)... Bakersfield, California (PRWEB) March 06, 2015 ... $5.7 million jury verdict on March 5, 2015 in ... County. According to court documents, a jury of 12 ... she suffered from being implanted with an Ethicon TVT ... of nine men and three women also awarded $5 ...
(Date:3/6/2015)... La (PRWEB) March 06, 2015 Many ... function despite medical therapy. If you (or someone you ... to knee osteoarthritis, you may be interested in the ... Covington Orthopedic announced today that he is one of ... Cytori Therapeutics to begin enrolling subjects as part of ...
(Date:3/6/2015)... Truly Nolen, the largest family-owned pest ... grand opening of their first independently-owned and operated franchise ... the Fort Mill – Rock Hill, SC area. The ... at their new location. , The Truly ... experience in the pest control industry. Locally owned and ...
(Date:3/6/2015)... TX (PRWEB) March 06, 2015 Yisrayl ... in Abilene, Texas, has released a new publication explaining ... working. , The article titled “Microorganisms Do ... document explaining how tiny microorganisms were created and designed ... is aware of some of the functions of these ...
Breaking Medicine News(10 mins):Health News:Cross Country Healthcare: Medical Doctor Associates Earns Inavero's 2015 Best of Staffing Talent Diamond Award 2Health News:Cross Country Healthcare: Medical Doctor Associates Earns Inavero's 2015 Best of Staffing Talent Diamond Award 3Health News:Johnson & Johnson Hit with $5.7 Million Verdict in Pelvic Mesh Trial Announces Matthews & Associates Law Firm 2Health News:Johnson & Johnson Hit with $5.7 Million Verdict in Pelvic Mesh Trial Announces Matthews & Associates Law Firm 3Health News:Kevin Darr, M.D. is Now Enrolling Patients in a New FDA-Approved Clinical Trial Evaluating Adipose-Derived Regenerative Cells in the Treatment of Knee Osteoarthritis 2Health News:First Truly Nolen Franchise Opening in North Carolina 2Health News:Yisrayl Hawkins Tells Scientists Exactly What Makes Life Function Properly in New Publication 2
... of America (ICA), formed three years ago ... informatics professionals at Vanderbilt Medical Center to ... the MidSouth eHealth Alliance (MSeHA) will transition ... version of the solution to support the ...
... The Agency for,Healthcare Research and Quality has ... reduce central line-associated bloodstream infections in,hospital intensive care ... previous AHRQ-funded project. The Health Research & Educational ... been selected to,coordinate the new 3-year project, which ...
... the growing need,for allied healthcare staff, Travel Nurse ... qualified allied travel candidates to participating,healthcare staffing agencies. ... with an extension to its successful travel nurse ... now have the opportunity to gain access to ...
... Highly Successful MHA Keystone: ICU Patient Safety Program, ... for Healthcare,Research and Quality (AHRQ) today announced a ... of hospital-associated infections,in intensive care units (ICUs)., ... efforts,of the Michigan Health & Hospital Association,s (MHA) ...
... 1 Per the Maryland Stem Cell,Commission (Commission) meeting ... official Requests for Applications (RFAs) for funding,through the Maryland ... Act. This is the third round of funding from ... budget of $19 million for FY,2009. However, it should ...
... BioForm Medical,Inc. (Nasdaq: BFRM ) announced today ... Group Growth Conference on Tuesday, October 7, 2008. Derek,Bertocci, ... a corporate overview of the Company at 2:30 p.m. ... the presentation will be webcast live and can be,accessed ...
Cached Medicine News:Health News: MidSouth eHealth Alliance to Transition to Commercial Software Solution from Informatics Corporation of America 2Health News: MidSouth eHealth Alliance to Transition to Commercial Software Solution from Informatics Corporation of America 3Health News:AHRQ Awards $3 Million to Help Reduce Central Line-Associated Bloodstream Infections in Hospital ICUs 2Health News:Travel Nurse Source Expands Lead Service to Allied Healthcare Travel Sector with Introduction of AlliedTravelCareers.com 2Health News:Michigan Success Lands National Research Contract to Reduce Hospital-Associated Infections in 10 States 2Health News:Maryland Stem Cell Commission Issues Requests for Applications 2Health News:Maryland Stem Cell Commission Issues Requests for Applications 3Health News:BioForm Medical to Present at the 2008 Maxim Group Growth Conference 2
... is a two-piece Titanium (Ti-6Al-4V) screw offered ... a variety of lengths. The two pieces ... sterile packaged. A single instrument set contains ... of both Standard and Mini Kompressor Compression ...
... with the IRIS Medical OcuLight GL ... EasyView slit lamp adapter (SLA) adds ... photocoagulation,to your existing Haag-Streit slit lamp, ... glaucoma,without compromising the diagnostic functions of ...
All purpose, low profile punches with a large square bite....
... design provides fingertip ratchet disengagement allowing smooth, ... program offers state-of-the-art quality in an instrument ... and durability. Low profile cutting tips allow ... Series I instruments are available in just ...
Medicine Products: